Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Oh my. The whole room is in......(Matt here)
I have some MBTX too
Took a starter here today @.70. Looking for the move to begin in about 2 weeks... best to beat the crowd.
All the information came from the company...not some board poster
copy paste copy paste
So you take your investing advice from podcasts? Nice. Did they recommend that stellar drink company that your upside down on? Ouch.
Making stuff up again
More dumping coming soon according to the podcast. Yikes.
Not all biotechs move immediately. Yes, AVXL and CYDY did, but that's because major catalysts followed shortly after. JBEM's DD told interested investors that the larger catalysts would come this summer. He even discussed the 3 abstracts as not being catalysts, but spreading the word on the company. MBVX has a lot of potential.
Sub-penny stock pumpers and self proclaimed millionaires such as yourself should stay in their lane. You're the biggest EQLB bag holder out there; waiting for this summer to finally help recover your losses. MBVX is not going to make everyone money over night, just like EQLB. Patience is key.
I agree. Letting this one play out.
Too soon to tell for sure. With catalysts approaching in June and July it should start moving soon , wouldn't you agree ?
That's an insanely naive statement. Especially considering the likes of phillip frost and OPKO are invested big here. Are we to assume you know more than the billionaire investor, and he got caught up in an amateur pump? Hah!
How this amateur pump job going? People still buy into these silly calls?
Could be, who knows. Going to see how it goes. MBVX was recently highlighted as a buyout candidate.
http://finance.yahoo.com/news/does-biotech-recent-bounce-legs-224954879.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAMxZmJkaDF0YmhtdGRuBGcDZFhWcFpEeHVjejR5TkRkalltWTNOUzFsTm1Oa0xUTmxNR1V0WW1FNU1DMDBaalJoWVRNd05qSmxabUU4Wm1sbGJHUStiV0oyZUE9PQRsYW5nA2VuLVVTBG9yaWdfbGFuZwNlbgRvcmlnX3JlZ2lvbgNVUwRwb3MDMARyZWdpb24DVVMEc3ltYm9sA01CVlg-?.tsrc=applewf
Bullish hammer candlestick bounced off of 50dma/bottom Bollinger band.
Techs: Charts clearly signalling a reversal, positive momentum on high volume after a long period on negative momentum, RSI Stochs resetting for next leg up after hitting multi-year resistance at 85. I'm long ...lucky to pick up some at 62 today. Great pick by JBEM as fundamentals are strong and the larger biotech sector is picking up strength, expecting any selling here to be short lived and soon to be matched by buyers accumulating; GLTALs.
days low .61, put a knife in it...
nobody at presentation got thrilled? dropped every since.
Got a starter in this morning.
Another big downside is very long trial cycle - getting pancreatic cancer patients - treating them and waiting for results - and 60 of them - very long wait and it needs a lot of funding - so it is very long shot
Jbem can't win them all . Looks like another sngx
Jbem just posted on Bob's board that he is being patient with this one-- see Bob's and Jbem's board for his post! I am patient too here! : ) : ) : ) MBVX $$$$$$$$$$$$$$!!!!!!!!!!!
Did you read jbem's DD? If so, you wouldnt be saying that.
doubt this holds...
Its why they are under a buck,
watch it get to .50 then a reverse,
guess that Three Presentations at AACR Annual Meeting didn't move heads.. down 16% since
I honestly don't pay any attention to him but just see when he's actively pumping across multiple message boards and noticed it's always someone else pick.
You don't remember FLXN? He pumped that up real good and then it dropped 50 percent asap. Jbem was not publicly involved with that pick.
nope, straight down...LOL
Why would I play them on my own when I can simply follow jbem's DD and make over 300% a year? I'm in this for the money, not the recognition. Couldn't care less how I get the money. I'm more than willing to check my ego at the door and follow the best in the business.
Priceless, considering I don't think I've seen a post from you touting a pick you've made on your own.
It still amazes me that some of you guys don't know the difference between a pump and dump and simply spreading the word heavily for a few days on very lightly traded yet undervalued stocks, which rise and continue to rise.
Yep, AVXL, TPIV, TRVN, CALA, all pump and dumps. LMAO. It's no surprise to me that you are still holding a bag with TNXP. You have a lot to learn about the market.
Looks like the pump's gone sour.
123tom claimed jbem asked him to join the group but I don't put much weight in that. Any weight really. That guy is special. Sal posts under a few handles but I enjoy his antics. Best to enjoy the show and make your own decisions.
You can believe what you want but the fact is you are wrong. Secondly, I don't think there has been a JBEM pick yet that didn't dip to well below the price on the day of the pick before it exploded. That's why the guy is the best in the business. He's not running a pump and dump and shitty companies. He is picking gems that just all about all provide great returns over time.
MM naked shorting is my guess. The all time company volume record was broken on Friday. People need to give it more than three days. This will be fine. CYDY dropped for four days to well below the price on the day JBEM picked it and then it ran over 50%.
I'm thankful to have a better entry. It doesn't take a lot of DD to realize this one is ridiculously undervalued. Very, very easy multi bagger in a matter of months IMO.
Sal is one of the insiders within the JBEM group. They get in early but in general most People that invest in his picks make money anyways.
Why is it selling off?
The guy puts out great info and brings awareness to good companies. He also doesn't alert his sells like some do ($heff), which usually damages these small bios in the short term.
I think he's a genuinely good guy but gets a bad rep because people think he's front loading. He very well could but he's gotta be rewarded for the amount of dd he provides for free. The pumpers that follow him tarnish his rep and I've talked to him about it. He claims he doesn't know them and can't control them and I'll give him the benefit of the doubt on it.
Haha let's set our sights low and then be pleasantly surprised with the 20 bagger.
Jbem seems like an ok guy, but unfortunately his pumping clowns tarnish his work. Then again, it is all part of the same deal.
recommendation/ pump
just sematics...
gotta watch the otc crap
Stocks only go up temporarily after JBEM makes a recommendation. From there, the company does the rest. The catalysts will come.
What's up with this stock? Has done nothing but go down since jbem jumped in.
Is this a 5 or 10 bagger? And is that all we can expect here? :)
I will try that and report back.
Followers
|
57
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1194
|
Created
|
04/12/01
|
Type
|
Free
|
Moderators |
| MabVax Therapeutics Holdings is a clinical-stage biopharmaceutical company focused on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. We generate our pipeline of antibody-based product candidates from patients who have been vaccinated with propriety vaccines licensed from Memorial Sloan-Kettering Cancer Center, or MSKCC. Our approach of surveying the protective immune response from many patients to identify the ideal monoclonal antibody candidate against a specific target on the surface of a cancer cell is a novel next-generation human antibody technology platform. Our approach to antibody discovery is to seek to identify the antibody candidates with superior performance characteristics while minimizing many of the toxicity and off target binding drawbacks of other discovery technologies. Our lead antibody candidates have been recovered from patients who had substantially better treatment outcomes than almost all other patients in clinical trials we conducted or that were conducted by our partners. Our therapeutic vaccines were developed at MSKCC and are exclusively licensed to us pursuant to agreements with MSKCC in 2008. These vaccines are administered in the adjuvant (period following conventional treatment consisting of watchful waiting) setting and have shown in clinical studies to elicit a protective antibody response. The antibodies are intended to seek out circulating tumor cells and micrometastases (small clusters of cancer cells) to kill them before they can cause cancer recurrence. Our lead cancer vaccines targeting recurrent sarcoma (soft tissue cancer) and ovarian cancer are currently in proof of concept Phase II multi-center clinical trials. Both trials have received substantial federal grant monies to support their development. A vaccine to address the orphan disease neuroblastoma (cancer starting in the adrenal gland of children which may spread to nervous tissue and bone marrow) has completed an initial Phase I trial at MSKCC and is expected be ready for a Phase II trial by early 2015. MSKCC and the Company have completed additional Phase I vaccine clinical trials in melanoma, ovarian cancer, and small cell lung cancer over the last three years.MBVX Intraday Stock Chart
My Stocks Activity For MBVX
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |